Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0000899243-20-017498

10% owner sold 255,000 shares at an average $24.72 ($6,304,373)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BRATTON DOUGLAS K 10% owner 2020-06-19 Sale −82,481 $24.20 $1,995,653 870,554 I
BRATTON DOUGLAS K 10% owner 2020-06-19 Sale −62,439 $25.00 $1,560,850 808,115 I
BRATTON DOUGLAS K 10% owner 2020-06-22 Sale −65,373 $24.66 $1,611,941 742,742 I
BRATTON DOUGLAS K 10% owner 2020-06-22 Sale −24,683 $25.12 $619,960 718,059 I
BRATTON DOUGLAS K 10% owner 2020-06-23 Sale −16,777 $25.69 $430,941 701,282 I
BRATTON DOUGLAS K 10% owner 2020-06-23 Sale −3,247 $26.19 $85,028 698,035 I
Open-market sales · 255,000 sh · avg $24.72 · $6,304,373
Loading xslF345X03/doc4.xml…